Author, year | Total population | Age, mean ± SD or mean and (range) | Pleural empyema stage | Treatment | |||
---|---|---|---|---|---|---|---|
Chest tube | VATS | Open | |||||
Uniportal | Multiportal | ||||||
Landreneau et al. [23] | 76 | 47 [14–78] | II-III | 0 | 0 | 76 | 0 |
Wait et al. [19] | 20 | VATS 42 ± 20/CT 43 ± 13 | II | 9 | 0 | 11 | 0 |
Angelillo Mackinlav et al. (24) | 64 | VATS 48.9 ± 17.6/ Open 51.1 ± 17.8 | II | 0 | 0 | 31 | 33 |
Cassina et al. [27] | 45 | 52 [13–86] | II | 0 | 0 | 45 | 0 |
Roberts et al. [25] | 172 | 53.68 [13–86] | II-III | 0 | 0 | 66 | 106 |
Kim et al. [28] | 70 | 40 ± 15 | II-III | 0 | 0 | 70 | 0 |
Lardinois et al. [29] | 328 | 55 [3–92] | II | 0 | 0 | 178 | 150 |
Solaini et al. [30] | 110 | 52 [7–88] | II-III | 0 | 0 | 110 | 0 |
Cardillo et al. [21] | 308 | VATS 55.8 ± 10.6/Open 57 ± 12.9 | II-III | 0 | 0 | 185 | 123 |
Stefani et al. [31] | 97 | 54 [21–83] | II-III | 0 | 0 | 97 | 0 |
Bongiolatti et al. [32] | 64 | 57.8 ± 16.4 | II-III | 0 | 30 | 0 | 34 |
Ismail et al. [22] | 35 | 57.26 ± 18.29 | I-II-III | 0 | 35 | 0 | 0 |
Semenkovich et al. [33] | 4095 | CT 64 [11]/ VATS 56 [45–69]/ Open 57 [47–69] | II | 1563 | 1313 | 0 | 1219 |
van Middendorp et al. [26] | 186 | u-VATS 60 ± 15.2/ m-VATS 59.6 ± 14.8 | II-III | 0 | 49 | 137 | 0 |